We are live on
!
Find out more
DIM
DC Investments Management Portfolio holdings
AUM
$261M
1-Year Est. Return
20.71%
This Fund
S&P 500
This Quarter
Est. Return
+3.69%
1 Year Est. Return
+20.71%
3 Year Est. Return
+44.71%
5 Year Est. Return
+36.74%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$8.18M
(+5.5%)
Cap. Flow
+$6.12M
Cap. Flow
% of AUM
3.89%
Top 10 Holdings %
Top 10 Hldgs %
6.71%
Holding
424
New
174
Increased
42
Reduced
68
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evergy
EVRG
|
+$1.09M |
| 2 |
AerCap
AER
|
+$863K |
| 3 |
GRMN
Garmin
GRMN
|
+$838K |
| 4 |
GSK
GSK
|
+$820K |
| 5 |
SF
Stifel
SF
|
+$818K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.51M |
| 2 |
Amgen
AMGN
|
+$2.11M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.68M |
| 4 |
Northrop Grumman
NOC
|
+$1.55M |
| 5 |
Becton Dickinson
BDX
|
+$1.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.87% |
| 2 | Financials | 19.67% |
| 3 | Technology | 12.25% |
| 4 | Real Estate | 10.82% |
| 5 | Utilities | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Crown Holdings
CCK
$13.2B
| $478K | 0.3% |
10,686
+5,997
| +128% | +$281K |
|
227
Leidos
LDOS
$17B
| $476K | 0.3% |
+8,070
| New | +$503K |
|
228
Hubbell
HUBB
$26.8B
| $471K | 0.3% |
+4,452
| New | +$493K |
|
229
L3Harris
LHX
$53.9B
| $465K | 0.3% |
3,218
-196
| -6% | -$30.3K |
|
230
Reinsurance Group of America
RGA
$15.5B
| $465K | 0.3% |
+3,486
| New | +$520K |
|
231
Travelers Companies
TRV
$80.5B
| $465K | 0.3% |
3,804
-9,996
| -72% | -$1.31M |
|
232
Carnival Corporation Ltd
CCL
$39.4B
| $463K | 0.29% |
8,079
+507
| +7% | +$32.2K |
|
|
FLG
233
Flagstar Bank National Association
FLG
$5.9B
| $459K | 0.29% |
+13,844
| New | +$498K |
|
234
MeiraGTx Holdings
MGTX
$1.18B
| $458K | 0.29% |
+40,000
| New | +$536K |
|
235
Ingredion
INGR
$6.49B
| $454K | 0.29% |
+4,097
| New | +$482K |
|
236
Assurant
AIZ
$14.7B
| $452K | 0.29% |
+4,364
| New | +$410K |
|
237
Sempra
SRE
$55.1B
| $451K | 0.29% |
7,774
-9,962
| -56% | -$545K |
|
238
Cummins
CMI
$88.7B
| $442K | 0.28% |
+3,324
| New | +$498K |
|
|
BERY
239
DELISTED
Berry Global Group, Inc.
BERY
| $441K | 0.28% |
+10,448
| New | +$485K |
|
240
Wayfair
W
$14.3B
| $438K | 0.28% |
+3,685
| New | +$320K |
|
|
EVLO
241
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $436K | 0.28% |
+1,846
| New | +$538K |
|
242
Columbia Financial
CLBK
$1.13B
| $429K | 0.27% |
+25,940
| New | +$431K |
|
|
DAY
243
DELISTED
Dayforce
DAY
| $425K | 0.27% |
+12,816
| New | +$451K |
|
|
STI
244
DELISTED
SunTrust Banks, Inc.
STI
| $423K | 0.27% |
+6,404
| New | +$435K |
|
245
DXC Technology
DXC
$1.77B
| $421K | 0.27% |
+5,220
| New | +$449K |
|
|
JWN
246
DELISTED
Nordstrom
JWN
| $416K | 0.26% |
+8,032
| New | +$398K |
|
|
AMTD
247
DELISTED
TD Ameritrade Holding Corp
AMTD
| $416K | 0.26% |
+7,599
| New | +$453K |
|
248
Nice
NICE
$5.69B
| $414K | 0.26% |
+3,988
| New | +$404K |
|
249
White Mountains Insurance
WTM
$5.3B
| $410K | 0.26% |
+452
| New | +$398K |
|
|
ITRM
250
DELISTED
Iterum Therapeutics
ITRM
| $406K | 0.26% |
+2,517
| New | +$454K |
|
Similar funds
DC
AFC
TIG
NG
ICM
TSW
ACM
ASP
DC Investments Management's Q2 2018 Portfolio in Review
As of Q2 2018, DC Investments Management held 424 positions worth $157M, up 5.5% from $149M the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
DC Investments Management deployed $6.12M of net new capital in Q2 2018, opening 174 new positions and adding to 42 existing holdings. Its largest new stake was Evergy: 20,319 shares worth $1.14M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $2.51M trimmed.
- DC Investments Management's largest Q2 2018 buy was Evergy: 20,319 shares worth $1.14M.
- DC Investments Management added most to TotalEnergies in Q2 2018, an estimated $612K increase.
- DC Investments Management's biggest Q2 2018 reduction was Pfizer, cutting an estimated $2.51M.
- DC Investments Management fully exited Amgen in Q2 2018, selling an estimated $2.11M.
- DC Investments Management's ten largest holdings make up 6.7% of its $157M portfolio in Q2 2018.
- DC Investments Management opened 174 new positions and closed 139 in Q2 2018.
- DC Investments Management's portfolio value rose 5.5% quarter-over-quarter to $157M.
Based on DC Investments Management's 13F filing for Q2 2018, filed 3 Aug 2018.